I psoriasisforsøg 1 var opretholdelsen af PASI 75 signifikant bedre ved fortsat behandling sammenlignet med behandlingsophør (p < 0, 001).
In Psoriasis Study 1 maintenance of PASI 75 was significantly superior with continuous treatment compared with treatment withdrawal (p < 0.001).